Medicare PA Monthly Program Ongoing monthly program management for Medicare GLP-1 patients
This article covers everything you need to know about combining these treatments, from how they interact in your digestive system to which specific antibiotics might require extra monitoring
With the use of Semaglutide GLP-1 injection, we can provide long-term solutions for type 2 diabetes and obesity management
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management
Patients receive guidance and support from licensed providers throughout their medical weight loss program to help ensure care decisions are informed, consistent, and professionally managed
A mechanical small bowel obstruction was excluded on imaging, which showed no discrete transition point and instead demonstrated features consistent with small bowel pseudo-obstruction, including mural thickening and upstream bowel dilatation